Immunic, Inc. (IMUX)
12.70
-1.54
(-10.81%)
USD |
NASDAQ |
Sep 03, 16:00
12.70
0.00 (0.00%)
After-Hours: 18:24
Immunic Cash and Short Term Investments (Annual) : 15.48M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 15.48M |
| December 31, 2024 | 35.67M |
| December 31, 2023 | 46.67M |
| December 31, 2022 | 116.37M |
| December 31, 2021 | 86.86M |
| December 31, 2020 | 127.45M |
| December 31, 2019 | 29.37M |
| December 31, 2018 | 13.07M |
| Date | Value |
|---|---|
| December 31, 2017 | 56.90M |
| December 31, 2016 | 59.99M |
| December 31, 2015 | 83.95M |
| December 31, 2014 | 103.83M |
| December 31, 2013 | 39.15M |
| December 31, 2012 | 98.48M |
| December 31, 2011 | 0.803M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Sionna Therapeutics, Inc. | 235.88M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |